- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lymphoma, Non-Hodgkin in Canada
Total 1559 results
-
Spectrum Pharmaceuticals, IncCompletedNon-Hodgkins Lymphoma | Tumors | Hodgkins DiseaseUnited States, Canada
-
University Health Network, TorontoCompletedHodgkin's Lymphoma | Non Hodgkin's LymphomaCanada
-
Maisonneuve-Rosemont HospitalBayerUnknownNon-Hodgkins LymphomaCanada
-
The Hospital for Sick ChildrenCompleted
-
Genentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaUnited States, France, Canada, Netherlands
-
Alberta Health Services, CalgaryUnknownNon-Hodgkin LymphomaCanada
-
British Columbia Cancer AgencyHoffmann-La RocheActive, not recruitingLymphoma, Non-Hodgkin | Advanced Stage Diffuse Large B-Cell Non-Hodgkin's LymphomaCanada
-
Centre de recherche du Centre hospitalier universitaire...Unknown
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States, Canada
-
Université de SherbrookeUnknownLymphoma, Large-CellCanada
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Non-Hodgkins LymphomaCanada
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupUnknownB-cell Non Hodgkin Lymphoma | Mature B-cell Leukemia Burkitt-typeBelgium, France, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain, China
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid TumorCanada, United States
-
Hoffmann-La RocheCompletedNon-Hodgkin Lymphoma, Follicular LymphomaUnited Kingdom, Belgium, United States, Australia, Canada, Germany
-
AHS Cancer Control AlbertaAlberta Cancer Foundation; Celgene CorporationCompleted
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei Hospital; Beijing Lu Daopei HospitalUnknownNon-hodgkin's LymphomaChina
-
Mirati Therapeutics Inc.CompletedNon Hodgkin's Lymphoma | TumorsCanada, United States
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Canada, Spain, Taiwan, France, Australia, United Kingdom, Poland, Italy, Israel, Czechia, Germany, Russian Federation, Sweden
-
McGill UniversityMcGill University Health Centre/Research Institute of the McGill University...Unknown
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
Iksuda Therapeutics Ltd.RecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin LymphomaAustralia, Canada, United States
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
Pacylex PharmaceuticalsOzmosis Research Inc.RecruitingAdvanced Solid Tumor | B-cell Non Hodgkin LymphomaCanada
-
NCIC Clinical Trials GroupCompleted
-
MedImmune LLCNational Cancer Institute (NCI)CompletedNon-Hodgkin's Lymphoma | Acute Lymphoblastic LeukemiaUnited States, Canada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedLymphoma, Non-Hodgkin | Hodgkin's DiseaseCanada
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingLymphoma Non-Hodgkin | Agressive Lymphoma | Diffuse-large B-cell Lymphoma (DLBCL)United States, Canada
-
University Health Network, TorontoHoffmann-La Roche; Ozmosis Research Inc.CompletedLymphoma, Non-Hodgkin'sCanada
-
NCIC Clinical Trials GroupEli Lilly and CompanyCompleted
-
AHS Cancer Control AlbertaTom Baker Cancer CentreTerminatedFollicular Lymphoma | Hodgkin's Lymphoma - Relapsed/Refractory | Non-Hodgkin's Lymphoma - AggressiveCanada
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaBelgium, France, Italy, Spain, Canada, United States, Bulgaria, United Kingdom, Hungary, Georgia, Belarus, Czechia
-
AbbVie (prior sponsor, Abbott)CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Peripheral T-cell Lymphoma | Lymphoid Malignancies | Chronic Lymphoid LeukemiaUnited States, Canada
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States, Canada
-
Novartis PharmaceuticalsXOMA (US) LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States, Belgium, Canada, Italy, France, Hong Kong, Australia, United Kingdom, Singapore, Korea, Republic of, Germany
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
Bristol-Myers SquibbSeagen Inc.CompletedNon-Hodgkin's DiseaseUnited States, France, Canada, United Kingdom, Italy, Spain
-
BayerCompletedMedical OncologyCanada, United States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Novartis PharmaceuticalsGlaxoSmithKlineTerminatedNon-Hodgkin's LymphomaChina, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
-
Hoffmann-La RocheAbbVieCompletedFollicular LymphomaUnited States, Italy, Canada, Australia, Belgium, United Kingdom, Germany, France
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark
-
BiogenCompletedLow-Grade or Follicular B-Cell Non-Hodgkin's LymphomaUnited States, Canada
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Canada, Belgium, Poland, Czechia, Italy, France, Germany, Netherlands, Sweden
-
Janssen-Cilag Ltd.CompletedLymphoma | Leukemia | Multiple Myeloma | Non-Hodgkin | LymphoidArgentina, Colombia, Mexico, Panama, Brazil, Chile, Guatemala